LabCorp
LH
213,50 €
Share price
-1.58%
Change (1 day)
12.86%
Change (1 year)
Categories
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.
LabCorp (LH) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €7.93 Billion
According to LabCorp's latest financial reports the company's total liabilities are €7.93 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
LabCorp - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | €9.91 B | 24% |
| 2023-12-31 | €7.99 B | -14.61% |
| 2022-12-31 | €9.35 B | 5.04% |
| 2021-12-31 | €8.91 B | 3.26% |
| 2020-12-31 | €8.62 B | -7.57% |
| 2019-12-31 | €9.33 B | 16.17% |
| 2018-12-31 | €8.03 B | -2.07% |
| 2017-12-31 | €8.20 B | -1.06% |
| 2016-12-31 | €8.29 B | -0.81% |
| 2015-12-31 | €8.36 B | 127.88% |
| 2014-12-31 | €3.67 B | 13.76% |
| 2013-12-31 | €3.22 B | 5.19% |
| 2012-12-31 | €3.06 B | 11% |
| 2011-12-31 | €2.76 B | -0.7% |
| 2010-12-31 | €2.78 B | 45.93% |
| 2009-12-31 | €1.90 B | -6.8% |
| 2008-12-31 | €2.04 B | 13.02% |
| 2007-12-31 | €1.81 B | 18.02% |
| 2006-12-31 | €1.53 B | -8.71% |
| 2005-12-31 | €1.67 B | 40.08% |
| 2004-12-31 | €1.19 B | -0.6% |
| 2003-12-31 | €1.20 B | 30.2% |
| 2002-12-31 | €0.92 B | -3.06% |
| 2001-12-31 | €0.95 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | €7.48 B | -5.69% | 🇺🇸 USA |
 NeoGenomics
NEO | €0.60 B | -92.32% | 🇺🇸 USA |
 Enzo Biochem ENZB | €17.2 M | -99.78% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | €1.51 B | -80.98% | 🇺🇸 USA |
 Qiagen QGEN | €1.82 B | -76.97% | 🇳🇱 Netherlands |